Legal Opinion

In re Galena Biopharma, Inc. Securities Litigation

District Court, D. Oregon

Decided August 5, 2015No. Case No. 3:14-cv-367-SIPublishedCited by 15 opinions

1Opinion of the Court

*1156OPINION AND ORDER

MICHAEL H. SIMON, District Judge.

This putative class action securities fraud case is brought by shareholders (“Plaintiffs”) of Defendant Galena Biophar-ma, Inc. (“Galena” or “Company”). Plaintiffs allege that Galena, certain members of Galena’s Board of Directors (“Board”), and executive officers of Galena engaged in a fraudulent scheme to promote Galena and increase its stock price so that many of Galena’s officers and directors could (and did) sell their personally-owned Galena stock at artificially high prices, in a “pump and dump” insider trading scheme. Plaintiffs…

2Cases cited88 opinions

  1. Ashcroft v. IqbalSupreme Court of the United States · 2009
  2. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  3. Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
  4. Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
  5. Starr v. BacaCourt of Appeals for the Ninth Circuit · 2011

83 more not listed; retrieve them via the Exa API.

3Cited by15 opinions

  1. Ballesteros v. Galectin Therapeutics, Inc.Court of Appeals for the Eleventh Circuit · 2016
  2. In re Cannavest Corp. Sec. Litig.District Court, S.D. Illinois · 2018
  3. In re Plains All American Pipeline, L.P. Securities LitigationDistrict Court, S.D. Texas · 2017
  4. Schaffer Family Investors, LLC v. SonnierDistrict Court, C.D. California · 2015
  5. In re Galectin Therapeutics, Inc. Securities LitigationDistrict Court, N.D. Georgia · 2015

10 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API